| Title |
Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast CancerMHC-II Is an Immunotherapy Biomarker in Early Breast Cancer
|
|---|---|
| Published in |
Clinical Cancer Research, July 2021
|
| DOI | 10.1158/1078-0432.ccr-21-0607 |
| Pubmed ID | |
| Authors |
Paula I. Gonzalez-Ericsson, Julia D. Wulfkhule, Rosa I. Gallagher, Xiaopeng Sun, Margaret L. Axelrod, Quanhu Sheng, Na Luo, Henry Gomez, Violeta Sanchez, Melinda Sanders, Lajos Pusztai, Emanuel Petricoin, Kim R.M. Blenman, Justin M. Balko, Avera Cancer Institute, B. Leyland-Jones, Colombia Cancer Agency, S. Chia, R. Serpanchy, C. Yu, Emory University, S. McMillan, R. Mosley, K. Nguyen, E.C. Wood, A. Zelnak, Georgetown University, C. Dillis, R. Donnelly, T. Harrington, C. Isaacs, B. Kallakury, M. Liu, F. Lynce, B. Oppong, P. Pohlmann, E. Tousimis, R. Warren, S. Willey, J.E. Wong, J. Zeck, Loyola University Chicago Medical Center, K. Albain, M.B. Bartolotta, D. Bova, C. Brooks, B. Busby, K. Czaplicki, X. Duan, R. Gamez, K. Ganesh, E. Gaynor, C. Godellas, C. Grace-Louthen, T. Kuritza, S. Lo, A. Nagamine, C. Perez, P. Robinson, D. Rosi, F. Vaince, K. Ward, Inova Fairfax Hospital, K. Choquette, K. Edmiston, H. Gallimore, J. McGovern, K. Mokarem, M. Pajaniappan, S. Rassulova, K. Scott, K. Sherwood, J. Wright, Arizona Mayo Clinic, K.S. Anderson, R.J. Gray, S.J. Myers, D.E. Northfelt, B.A. Pockaj, J. Roedig, N. Wasif, Rochester Mayo Clinic, A.M. Arens, J.C. Boughey, K.R. Brandt, J.L. Carroll, B. Chen, A.L. Connors, A.C. Degnim, D.R. Farley, S.M. Greenlee, T.C. Haddad, T.J. Hieken, T.J. Hobday, J.W. Jakub, L.L. Liberte, M.C. Liu, C.L. Loprinzi, L.R. Menard, M.M. Moe, T.J. Moynihan, C. O'Sullivan, E.A. Olson, P.P. Peethambaram, K.J. Ruddy, B.A. Russell, A.L. Rynearson, D.R. Smith, D.W. Visscher, A.J. Windish, H. Lee Moffitt Cancer Center and Research Institute, K. Cox, K. Dawson, O. Newton, W. Ramirez, Oregon Health and Science University, H. Bengtson, J. Bucher, S. Chui, B. Gilbert-Ghormley, R. Hampton, K.A. Kemmer, D. Kurdyla, D. Nauman, J. Spear, A. Wilson, Swedish Cancer Institute, D. Beatty, P. Dawson, E.R. Ellis, M. Fer, J. Hanson, M.P. Goetz, T.C. Haddad, D. Iriarte, H.G. Kaplan, B. Porter, K. Rinn, H. Thomas, S. Thornton, R. Tickman, N. Varghis, University of Alabama at Birmingham, V. Caterinichia, J. Delos Santos, C. Falkson, A. Forero, H. Krontiras, C. Vaklavas, S. Wei, University of Arizona, A. Bauland, L. Inclan, D. Lewallen, A. Powell, C. Roney, K. Schmidt, R.K. Viscusi, H. Wright, San Diego University of California, S. Blair, S. Boles, J. Bykowski, B. Datnow, L. Densley, M. Eghtedari, V. Genna, F. Hasteh, T. Helsten, P. Kormanik, H. Ojeda-Fournier, I. Onyeacholem, B. Parker, K. Podsada, R. Schwab, A. Wallace, C. Yashar, San Francisco University of California, M.D. Alvarado, A. Au, R. Balassanian, C. Benz, M. Buxton, Y.Y. Chen, J. Chien, C. D'Andrea, S.E. Davis, L. Esserman, C. Ewing, A. Goga, G.L. Hirst, M. Hwang, N. Hylton, B. Joe, J. Lyandres, M. Kadafour, G. Krings, M. Melisko, M. Moasser, P. Munter, Z. Ngo, J. Park, E. Price, H. Rugo, L. van't Veer, J. Wong, C. Yau, University of Chicago, H. Abe, N.T. Jaskowiak, R. Nanda, F. Olopade, D.V. Schacht, Denver University of Colorado, V. Borges, T. Colvin, J. Diamond, A.D. Elias, C. Finlayson, C. Fisher, L. Hardesty, P. Kabos, N. Kounalakis, J. Mayordomo, T. McSpadden, C. Murphy, R. Rabinovitch, S. Sams, E. Shagisultanova, University of Kansas, S. Baccaray, Q. Khan, University of Minnesota, H. Beckwith, A. Blaes, T. Emory, T.C. Haddad, J. Hui, M. Klein, J. Kuehn-Hajder, M. Nelson, D. Potter, T. Tuttle, D. Yee, R. Zera, University of Pennsylvania, L. Bayne, A. Bradbury, A. Clark, A. DeMichele, S. Domchek, C. Fisher, K. Fox, D. Frazee, M. Lackaye, J. Matro, E. McDonald, M. Rosen, P. Shah, J. Tchou, M. Volpe, University of Texas MD Anderson Cancer Center, R. Alvarez, C. Barcenas, D.A. Berry, D. Booser, A. Brewster, P. Brown, A. Gonzalez-Angulo, N. Ibrahim, M. Karuturi, K. Koenig, S. Moulder, J. Murray, R. Murthy, L. Pusztai, B. Saigal, W.F. Symmans, D. Tripathy, R. Theriault, N. Ueno, V. Valero, University of Southern California, M. Brown, M. Carranza, Y. Flores, J. Lang, A. Luna, N. Perez, D. Tripathy, K. Watkins, University of Texas Southwestern Medical Center, S. Armstrong, C. Boyd, L. Chen, V. Clark, A. Frankel, D.M. Euhus, T. Froehlich, S. Goudreau, B. Haley, A. Harker-Murray, D. Klemow, A.M. Leitch, R. Leon, H. Li, T. Morgan, N. Qureshi, R. Rao, M. Reeves, A. Rivers, N. Sadeghi, S. Seiler, B. Staves, V. Tagoe, G. Thomas, D. Tripathy, N. Unni, S. Weyandt, R. Wooldridge, J. Zuckerman, Universty of Washington, L. Korde, M. Griffin, B. Butler, A. Cundy, L. Rubinstein, C. Hixson |
X Demographics
The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 10 | 37% |
| Italy | 1 | 4% |
| India | 1 | 4% |
| United Kingdom | 1 | 4% |
| Ireland | 1 | 4% |
| Australia | 1 | 4% |
| Sri Lanka | 1 | 4% |
| Brazil | 1 | 4% |
| Japan | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 9 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 56% |
| Scientists | 6 | 22% |
| Practitioners (doctors, other healthcare professionals) | 4 | 15% |
| Science communicators (journalists, bloggers, editors) | 2 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 45 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 8 | 18% |
| Student > Postgraduate | 6 | 13% |
| Student > Ph. D. Student | 5 | 11% |
| Lecturer | 1 | 2% |
| Student > Doctoral Student | 1 | 2% |
| Other | 4 | 9% |
| Unknown | 20 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 24% |
| Biochemistry, Genetics and Molecular Biology | 4 | 9% |
| Immunology and Microbiology | 2 | 4% |
| Business, Management and Accounting | 1 | 2% |
| Nursing and Health Professions | 1 | 2% |
| Other | 5 | 11% |
| Unknown | 21 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 173. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 June 2023.
All research outputs
#230,125
of 25,200,621 outputs
Outputs from Clinical Cancer Research
#100
of 13,194 outputs
Outputs of similar age
#6,141
of 427,881 outputs
Outputs of similar age from Clinical Cancer Research
#4
of 152 outputs
Altmetric has tracked 25,200,621 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,194 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,881 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 152 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.